PHARMACOEPIDEMIOLOGY : A REVIEW

Authors

  • Srishti Upadhyay Department of Pharmacology, Kota College of Pharmacy, Kota, Rajasthan, India
  • Saumya Shrivastava Department of Pharmacology, Kota College of Pharmacy, Kota, Rajasthan, India
  • Deepak Kumar Department of Pharmacology, Kota College of Pharmacy, Kota, Rajasthan, India
  • Atul Kabra Department of Pharmacology, Kota College of Pharmacy, Kota, Rajasthan, India
  • Uttam Singh Baghel Department of Pharmacology, Kota College of Pharmacy, Kota, Rajasthan, India

DOI:

https://doi.org/10.22270/ajprd.v7i2.464

Keywords:

Pharmacoepidemiology, epidemiology, drug utilization

Abstract

Pharmacoepidemiology is the study of the use of drugs in a large number of people.It is a growing discipline that applies epidemiological techniques to study drugs used in a large population. Just as the term implies, pharmacoepidemiology combines clinical pharmacology with epidemiology. Pharmacology is the study of the effects of medications on humans; it pertains to using pharmacokinetic and pharmacodynamic parameters of patients to predict the effect of drugs. Epidemiology, on the other hand, is the study of the factors that determine the occurrence and distribution of diseases in a population. In its broad concept, it encompasses drug utilization studies, and identification and quantification of adverse drug reactions (ADRs); its aim is to improve the quality and use of medicines. Drug utilization studies are known to involve the marketing, distribution, prescription, and use of drugs in a society with special emphasis on the medical, social, and economic consequences. The discipline, when not considered sufficiently, has a potential that could cause a high-level of increase in health expenses by creating conflict in the health systems of countries. In this study, it is aimed to define pharmacoepidemiology, to analyze its relation with other disciplines and to inform about pharmacoepidemiology usage areas.

 

Downloads

Download data is not yet available.

Author Biographies

Srishti Upadhyay, Department of Pharmacology, Kota College of Pharmacy, Kota, Rajasthan, India

Department of Pharmacology, Kota College of Pharmacy, Kota, Rajasthan, India

Saumya Shrivastava, Department of Pharmacology, Kota College of Pharmacy, Kota, Rajasthan, India

Department of Pharmacology, Kota College of Pharmacy, Kota, Rajasthan, India

Deepak Kumar, Department of Pharmacology, Kota College of Pharmacy, Kota, Rajasthan, India

Department of Pharmacology, Kota College of Pharmacy, Kota, Rajasthan, India

Atul Kabra, Department of Pharmacology, Kota College of Pharmacy, Kota, Rajasthan, India

Department of Pharmacology, Kota College of Pharmacy, Kota, Rajasthan, India

Uttam Singh Baghel, Department of Pharmacology, Kota College of Pharmacy, Kota, Rajasthan, India

Department of Pharmacology, Kota College of Pharmacy, Kota, Rajasthan, India

References

1. Strom BL, Kimmel SE, Hennessy S. Pharmacoepidemiology, Edition 3, Wiley-Blackwell; 2000.
2. Lawson D.H. Pharmacoepidemiology: A New Discipline, British Medical Journal, 1984; 289(6450):940-941.
3. Etminan M, Samii A.. Pharmacoepidemiology I: A Review of Pharmacoepidemiologic Study Designs. Pharmacotherapy, 2004; 24(8):964–969.
4. Bergman U. Pharmaco-epidemiological perspectives, Pharmaceutical Weekblad, 11(5), 1989, 151-4.
5. Briggs AH, Levy AR. Pharmacoeconomics and Pharmacoepidemiology: Curious Bedfellows or a Match Made in Heaven, Pharmacoeconomics, 2006; 24(11):1079-1086.
6. Epstein M. Guidelines for good pharmacoepidemiology practices (GPP), Pharmacoepidemiology and Drug Safety, 2005; 14:589–595.
7. Law MT. How do Regulators Regulate? Enforcement of the Pure Food and Drugs Act, 1907–38, The Journal of Law, Economics & Organization, 2000; 22(2):459-489.
8. Botting J. The History of Thalidomide. Drug News Perspect, 2002;15(9):604.
9. Collier J. Paediatric Prescribing: Using Unlicensed Drugs and Medicines Outside Their Licensed Indications, British Journal of Clinical Pharmacology, 1999; 48(1):5-8.
10. Drug Lag by Daniel Henninger,http://www.econlib.org/library/Enc1/DrugLag.html
11. Wardell WM. The drug lag revisited: comparison by therapeutic area of patterns of drugs marketed in the United States and Great Britain from 1972 through 1976, Clinical Pharmacology & Therapeutics, 1978; 24:499-524.
12. Bhaven CK, Mehta D, Mehta S. Drug Lag for Antimicrobial Agents: Comparison of the USA. Europe and India Approvals, National Journal of Medical Research, 2012; 2(3): 264-268.
13. Boston Collaborative Drug Surveillance Program, BCDSP – Pharmacoepidemiology and Drug Safety Research, http://www.bu.edu/bcdsp
14. Avorn J. The Role of Pharmacoepidemiology and Pharmacoeconomics in Promoting Access and Stimulating Innovation, Pharmacoeconomics, 2004; 22(2):81-86.
15. Jones JK. Pharmacogenetics and Pharmacoepidemiology, Pharmacoepidemiology and Drug Safety, 2001; 10(5):457–461.
16. Waller P. Pharmacoepidemiology-A Tool for Public Health, Pharmacoepidemiology and Drug Safety, 2001; 10(2): 165–172.
17. Lee JAH, Draper PA, Weatherall M.. Prescribing in Three English Towns, Milbank Memorial Fund - The Milbank Quarterly, 1965.
18. Muller C, Outpatient drug prescribing by general practice. British Medical Journal, 1968; 1: 671-674.
19. Routledge PA. Adverse drug reactions and interactions: mechanisms, risk factors, detection, management and prevention, in J Talbot, P Waller (Ed.), Stephens' Detection of New Adverse Drug Reactions, 4 (John Wiley & Sons Ltd, 2004).
20. HA Guess. Premarketing Applications of Pharmacoepidemiology, In Pharmacoepidemiology, in BL Strom (Ed.), Wiley-Blackwell, 4, 2005.
21. A Acar, S. Yeğenoğlu, Sağlık Ekonomisi, Perspektifinden Farmakoekonomi, Hacettepe University, Journal of the Faculty of Pharmacy, 2006; 26(1):39-55.
22. Pinar Yalcin Balcik, Gulcan Kahraman. Pharmacoepidemiology, IOSR Journal Of Pharmacy, 2016; 6(2):57-62
23. Jones JK. Pharmacogenetics and Pharmacoepidemiology, Pharmacoepidemiology and Drug Safety, 2001; 10(5):457–461

Published

2019-04-15

How to Cite

Upadhyay, S., Shrivastava, S., Kumar, D., Kabra, A., & Baghel, U. S. (2019). PHARMACOEPIDEMIOLOGY : A REVIEW. Asian Journal of Pharmaceutical Research and Development, 7(2), 83–87. https://doi.org/10.22270/ajprd.v7i2.464

Most read articles by the same author(s)